Sickle Cell Disease
An inherited haemoglobinopathy in which deoxygenated haemoglobin S polymerises, making red cells rigid and adhesive; vaso-occlusion causes ischaemic pain while haemolysis causes chronic anaemia and progressive organ damage.
In a nutshell
Sickle cell disease is chronic haemolysis punctuated by vaso-occlusive pain, in a patient whose spleen no longer works. Treat an acute painful episode as an emergency: give plan-matched analgesia within 30 minutes, then reassess every 30 minutes.
Classic presentation
A young adult with known HbSS presents with severe back and limb pain after a cold, wet weekend, on a background of jaundice and chronic anaemia.
Key points
- Fetal haemoglobin blocks haemoglobin S (HbS) polymerisation, so infants are protected for their first few months, and hydroxycarbamide works by raising it.
- CG143 gives no drug doses at all. It sets the timings and defers every dose to the BNF and the local protocol.
- Moderate pain is a visual analogue score of 4 to 7 and severe pain is above 7. CG143 uses those bands to choose weak or strong opioid.
- Acute chest syndrome can be triggered by fluid overload, opioid narcosis, hypoventilation or pulmonary embolism, so treating the pain badly can cause it.
- The BNF records a possible association between morphine given during a vaso-occlusive crisis and acute chest syndrome, and advises watching for it.
- CG143 dates from 2012, but NICE's 2023 exceptional surveillance found no reason to update any section of it, so it remains the current UK guideline.
- Newborn blood spot screening identifies sickle cell disease in England, and affected babies are referred for specialist care by 3 months of age.
First-line investigation
FBC and reticulocyte count against the patient's steady state, plus a group and screen; add chest X-ray and blood gas if saturations are 94% or below on air.
Management
The first 30 minutes
- Treat as an acute medical emergency. Offer analgesia within 30 minutes of arrival (CG143 recommendation 1.1.4). Do not wait for bloods, imaging or senior review.4,7
- Use the individual care plan and prior opioid exposure. If unavailable, an opioid-naive adult example is morphine 5 mg by slow IV injection, adjusted to response.4,9
- Untreated moderate pain: a weak opioid may suffice. Adult example: codeine 30 to 60 mg orally every 6 hours, adjusted for age and risk.4,10,9
- Record blood pressure, pulse, respiratory rate, temperature and saturations on air. Offer oxygen if saturations are 95% or below.4
Adjuncts and reassessment
- Regular paracetamol 1 g every 6 hours (maximum 4 g daily) plus an NSAID unless contraindicated. Avoid NSAIDs in the third trimester of pregnancy.4,11
- With opioids, offer a regular laxative. Give an antiemetic or antipruritic only if needed; adult examples are lactulose, cyclizine and chlorphenamine.4,12,13,14
- Reassess pain every 30 minutes until controlled, then at least 4-hourly. Still severe: second strong-opioid bolus. Repeated boluses within 2 hours: patient-controlled analgesia.4
- Sedation score and adverse-effect check hourly for the first 6 hours, then at least 4-hourly. Keep the patient warm and give fluids orally where possible.4
Acute chest syndrome and stroke
- Acute chest syndrome is fever and/or respiratory symptoms with a new infiltrate on chest X-ray. It can appear at any point in the admission, not only at presentation.5
- Arterial blood gas in adults if saturations are 94% or below on air. Give oxygen to hold saturations at 95% or above, or within 3% of baseline.5
- Antibiotics with atypical cover: co-amoxiclav 1.2 g intravenously every 8 hours plus clarithromycin 500 mg twice daily; ceftriaxone 2 g intravenously once daily if penicillin-allergic.5,15,16
- Add incentive spirometry, and a bronchodilator if there is bronchospasm. Involve critical care early for non-invasive or invasive ventilation.5
- Suspected acute ischaemic stroke: emergency exchange transfusion to HbS below 30%, alongside the hyperacute stroke pathway.8
Transfusion decisions
- Acute chest syndrome with hypoxia (PaO2 below 9.0 kPa on air): simple top-up transfusion to a target haemoglobin of 100 to 110 g/L.8
- Exchange transfusion for severe or progressive acute chest syndrome, failure to respond to top-up, or a haemoglobin already above 90 g/L.8,5
- Aplastic crisis and splenic sequestration: simple transfusion back to steady state only. Going above 80 g/L in sequestration risks hyperviscosity as the spleen releases cells.8
- Uncomplicated painful crisis: no transfusion, unless haemoglobin falls more than 20 g/L below baseline or below 50 g/L, or an organ is threatened.8
Preventing the next episode
- Phenoxymethylpenicillin 250 mg twice daily from age 5 and in adults, usually for life. Ages 1 to 4: 125 mg twice daily. Under 1 year: 62.5 mg twice daily.17,6
- Pneumococcal, meningococcal, Haemophilus influenzae type b and annual influenza vaccination, because the spleen no longer clears encapsulated organisms.1,5
- Folic acid 5 mg every 1 to 7 days, replacing what chronic haemolysis consumes.18
- Hydroxycarbamide 15 mg/kg daily, titrated to 15 to 30 mg/kg daily (maximum 35 mg/kg), for recurrent painful episodes or recurrent acute chest syndrome.19,5,8
- On hydroxycarbamide, check FBC every 2 weeks for the first 2 months, then every 2 to 3 months. Avoid it if the estimated glomerular filtration rate is below 30 mL/minute/1.73 m2.19
Discharge and surveillance
- Written discharge plan: stepping analgesia down, side effects to expect, how to reach the specialist team and how to obtain more medication.4
- Return urgently for fever, chest symptoms, new neurological signs, sudden pallor, persistent priapism or uncontrolled pain.4,3
- Children with HbSS or HbS-beta-zero thalassaemia have annual transcranial Doppler ultrasound from age 2 to 16 years to find those at high stroke risk.1,8
- Chronic transfusion, stem cell transplant and exagamglogene autotemcel (NICE TA1044, managed access, aged 12 and over) are specialist-only decisions.20,8
Exam traps
- The 30-minute target runs from arrival at hospital, not from the doctor seeing the patient, and bloods or imaging are not a reason to delay.
- Do not offer pethidine for an acute painful sickle cell episode. It is the one analgesic CG143 explicitly rules out (recommendation 1.1.11).
- Do not use corticosteroids in an uncomplicated acute painful episode (CG143 recommendation 1.1.21).
- An early normal chest X-ray does not exclude acute chest syndrome. Keep looking if the patient is hypoxic or has chest signs.
- Falling haemoglobin with a high reticulocyte count is sequestration or haemolysis; with a low reticulocyte count it is aplastic crisis from parvovirus B19.
- In sequestration, transfuse back to steady state only. Pushing haemoglobin above 80 g/L causes hyperviscosity when the sequestered cells re-enter the circulation.
- Transfusion does not shorten an uncomplicated painful crisis and is not given for pain alone.
- Annual transcranial Doppler screening is for children aged 2 to 16 with HbSS or HbS-beta-zero thalassaemia. It is not a routine adult test.
Illustrations
Key sources
- NHS England, Sickle cell and thalassaemia screening handbook: understanding haemoglobinopathiesPublished 6 Jul 2018 | Updated 11 Jul 2025
- British Society for Haematology, Guidelines for the use of hydroxycarbamide in children and adults with sickle cell diseasePublished 6 May 2018
- NHS, Sickle cell disease: symptomsPublished 23 Oct 2017 | Updated 30 Nov 2022
- NICE, Sickle cell disease: managing acute painful episodes in hospital (CG143)Published 27 Jun 2012
- British Society for Haematology, Management of acute chest syndrome in sickle cell diseasePublished 30 Mar 2015
- NHS, Sickle cell disease: treatmentPublished 23 Oct 2017 | Updated 30 Nov 2022
- NICE, Sickle cell disease quality standard, quality statement 1: timely assessment and analgesia (QS58)Published 10 Apr 2014
- British Society for Haematology, Guidelines on red cell transfusion in sickle cell disease, part II: indications for transfusion (2017)
- British National Formulary, Morphine: indications and dose, and monitoring in sickle cell disease
- British National Formulary, Codeine phosphate: short-term treatment of acute moderate pain
- British National Formulary, Paracetamol: indications and dose
- British National Formulary, Lactulose: indications and dose
- British National Formulary, Cyclizine: indications and dose
- British National Formulary, Chlorphenamine maleate: indications and dose
- British National Formulary, Co-amoxiclav: intravenous dose for beta-lactamase-producing infections
- British National Formulary, Ceftriaxone: indications and dose
- British National Formulary, Phenoxymethylpenicillin: prevention of pneumococcal infection in asplenia or sickle-cell disease
- British National Formulary, Folic acid: prophylaxis in chronic haemolytic states
- British National Formulary, Hydroxycarbamide: sickle-cell disease dosing (Siklos and Xromi) and monitoring requirements
- NICE, Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over (TA1044)Published 26 Feb 2025
- NICE, 2023 surveillance of sickle cell disease (CG143), appendix A: summary of evidence from surveillancePublished 1 Jun 2023
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

